Arovella Therapeutics Ltd has released a press release.
Arovella Therapeutics: Half Yearly Report and Accounts (including Appendix 4D)
Filed with ASX ·
6ix hasn’t read this filing yet.
Arovella Therapeutics Limited on 6ix
Story so far
Earlier from Arovella Therapeutics
- SUDA receives $0.7m R&D tax incentive refund
- Westcoast Surgical & Medical Supplies Update
- Westcoast Launches Novel Hemostyp Gauze
- Westcoast Expands Aged Care Activities
- Update on HC Berlin Pharma AG and Clinical Trials
Later from Arovella Therapeutics
- Westcoast Expands To East Coast
- Appendix 4D Half Year Ended 31 December 2013
- Suda Completes Successful $5.6m Capital Raising
- SUDA Signs Option To Acquire NovaMist Technology
- ArTiMist Update
Follow Arovella Therapeutics into a list and get an email when it puts out news.
Follow Arovella Therapeutics